Skip to main content
. 2021 Jun 22;9(9):3308–3320.e3. doi: 10.1016/j.jaip.2021.06.010

Figure 2.

Figure 2

Management of patients who present with symptoms concerning for an allergic reaction to the first dose of mRNA COVID-19 vaccine. Use of Janssen vaccine (if available) may be appropriate after allergic reaction to the first dose of mRNA COVID-19 vaccine if allergy evaluation is not feasible or owing to shared decision-making between the patient and physician. PEG, polyethylene glycol. ∗Same COVID-19 vaccine manufactured as first dose. †Limited supply of Janssen COVID vaccine; only use when clinically necessary.